Additionally, we made a groundbreaking discovery of IFI16’s downstream molecule, IL6, and confirmed the role of the IFI16/IL6/PI3K/AKT axis in ccRCC. The gene discussed is IFI16; the disease is nonpapillary renal cell carcinoma.